Write in a clean editor, then format for Journal of Diabetes in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Journal of Diabetes is a peer-reviewed journal published by Wiley, covering Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Diabetes Management and Research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Journal of Diabetes 12 (3): 45–58.
Formats any DOI in Journal of Diabetes style. No sign-up. |
| Publishes research in | Diabetes Treatment and Management Diabetes, Cardiovascular Risks, and Lipoproteins Diabetes Management and Research Diabetes and associated disorders Pancreatic function and diabetes |
| ISSN | 1753-0393 |
| Citation impact (2-yr) | 4.3 |
| h-index | 75 |
| i10-index | 893 |
| Total citations | 50,253 |
| Article processing charge | $3,000 |
| Open access | Yes |
| Top institutions publishing here | Icahn School of Medicine at Mount Sinai |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Ann M. Carracher, Payal H. Marathe, and Kelly L. Close are of Close Concerns (http://www.closeconcerns.com), a healthcare information company focused exclusively on diabetes and obesity care. Close Concerns publishes Closer Look, a periodical that brings together news and insights in these areas. Each month, the Journal of Diabetes includes this News feature, in which Carracher,…
Endothelial cells, as well as their major products nitric oxide (NO) and prostacyclin, play a key role in the regulation of vascular homeostasis. Diabetes mellitus is an important risk factor for cardiovascular disease. Diabetes-induced endothelial dysfunction is a critical and initiating factor in the genesis of diabetic vascular complications. The present review focuses on both…
BACKGROUND: Recently, a Joint Scientific Statement bridged differences between previous definitions of metabolic syndrome. Our objective was to estimate the prevalence of metabolic syndrome in a representative sample of US adults and to examine its correlates. METHODS: We analyzed data for up to 3461 participants aged ≥ 20 years of the 2003-2006 National Health and…
The American Diabetes Association’s (ADA) 2017 Standards of Care1 were published in Diabetes Care on 15 December 2016. Notable changes in the new guidelines include the recommendation of sodium-glucose cotransporter 2 (SGLT-2) inhibitor empagliflozin and glucagon-like peptide 1 (GLP-1) agonist liraglutide for type 2 diabetes (T2D) patients at high risk for cardiovascular morbidity and mortality.…
BACKGROUND: Oxidative stress, produced under diabetic conditions, may cause tissue damage. Although several drugs are currently available for the treatment of diabetes, their continued use may cause unwanted side effects. The aim of the present study was to evaluate the antioxidant potential of β-sitosterol (BS), a phytosterol from Solanum surattense, using an experimental model for…
